Home / Products / Cancer (Tumor) Cell Lines / KG-1a
KG-1a
Datasheet Protocol

KG-1a

Cat. No. ARC0391
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Bone (bone marrow)

Growth Properties:

Suspension

In stock
$1,300.00 / Vial
Ask a Question

Short Description 🔒

KG-1a is a cancer cell line of bone (bone marrow) acute myeloid leukemia (aml), isolated from in situ; bone marrow.
 
Synonym: KG1A

Recommended Products

FIBP Knockout HT29 Polyclonal Cells FIBP Knockout HT29 Polyclonal Cells Cat. No. ARG14059 FoxM1 Knockout CAL27 Polyclonal Cells FoxM1 Knockout CAL27 Polyclonal Cells Cat. No. ARG11611 PDCD4 Knockout Hela Polyclonal Cells PDCD4 Knockout Hela Polyclonal Cells Cat. No. ARG8291 LCN2 Knockout CaSki Polyclonal Cells LCN2 Knockout CaSki Polyclonal Cells Cat. No. ARG9814 CH25H Knockout MCF7 Polyclonal Cells CH25H Knockout MCF7 Polyclonal Cells Cat. No. ARG11436 MICALL1 Knockout 786-O Polyclonal Cells MICALL1 Knockout 786-O Polyclonal Cells Cat. No. ARG5579
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Bone (bone marrow)
Disease:
Acute myeloid leukemia (AML)
Growth Mode:
Suspension
Age:
59 years
Sex of Donor:
Male
Derived From Site:
In situ; Bone marrow
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

ENAH Knockout NCI-H1299 Polyclonal Cells

ENAH Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG17808
 DAG1 Knockout NCI-H1299 Polyclonal Cells

DAG1 Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG17591
 LDHA Knockout HT29 Polyclonal Cells

LDHA Knockout HT29 Polyclonal Cells

Cat. No. ARG14510
 CC2D1B Knockout Raji Polyclonal Cells

CC2D1B Knockout Raji Polyclonal Cells

Cat. No. ARG42841
 MARVELD2 Knockout NCI-H1299 Polyclonal Cells

MARVELD2 Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG17824
 CTSD Knockout HCT116 Polyclonal Cells

CTSD Knockout HCT116 Polyclonal Cells

Cat. No. ARG7162